about
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach ...
Read More
8.45
-0.03
(-0.35%)
12.2M
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
ImmunityBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..